<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Maeder MT</dc:creator>
  <dc:creator>Hack D</dc:creator>
  <dc:creator>Rickli H</dc:creator>
  <dc:creator>Rocca HP</dc:creator>
  <dc:creator>Riesen W</dc:creator>
  <dc:creator>Ammann P</dc:creator>
  <dc:date>2008</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">BACKGROUND
In patients with clinically stable chronic heart failure, circulating B-type natriuretic peptide (BNP) levels may exhibit considerable variation over a period of a few days. The aim of this study was to evaluate the clinical impact of this phenomenon.


METHODS
In 23 patients with clinically stable mild-to-moderate systolic heart failure [median (interquartile range) 72 (64-77) years, left ventricular ejection fraction 30 (27-40)%] and a history of previous hospitalization for heart failure, BNP was measured at two time points [T1 and T2, interval 5 (3-7) days] for calculation of the absolute change in BNP concentrations between T1 and T2 (DeltaBNP; irrespective of whether there was a decrease or increase). Follow-up for rehospitalization was 436 (407-458) days.


RESULTS
In the group overall, DeltaBNP was 26 (9-116) pg/ml [19 (10-28)% of the value at T1]. During follow-up, 8/23 (35%) patients were rehospitalized. BNP concentrations at T1 [340 (187-533) vs. 210 (108-606) pg/ml; P = 0.33] and T2 [328 (125-491) vs. 259 (89-536) pg/ml; P = 0.51] were similar in patients who were rehospitalized and those who were not; however, DeltaBNP was higher in patients requiring rehospitalization [98 (36-186) vs. 19 (6-93) pg/ml; P = 0.04]. Patients with DeltaBNP &lt;26 pg/ml had a longer rehospitalization-free survival than those with DeltaBNP &gt; or = 26 pg/ml (log rank P = 0.02). Sensitivity and specificity of DeltaBNP &gt; or = 26 pg/ml for the prediction of rehospitalization were 88% and 67% respectively.


CONCLUSIONS
In this small study among patients with clinically stable heart failure, higher DeltaBNP over a period of a few days was associated with a higher likelihood of rehospitalization during follow-up.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/186412</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00508-008-1099-x</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/19116708</dc:relation>
  <dc:source>Wiener klinische Wochenschrift. - 2008</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Heart Failure</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Natriuretic Peptide, Brain</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Reproducibility of Results</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Sensitivity and Specificity</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Statistics as Topic</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Time Factors</dc:subject>
  <dc:title xmlns:ns12="xml" ns12:lang="en">Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
